BILLERICA, Mass., Jan. 2, 2018 /PRNewswire/ -- Bruker Corporation
(NASDAQ: BRKR) announced today it will participate in the
36th annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO and
Tony Mattacchione, Senior Vice
President and CFO will present on behalf of the company on
Monday, January 8th, 2018
at 10:00 AM Pacific
Time.
A live audio webcast of the presentation will be available on
the Investor Relations section of the Company's web site at
ir.bruker.com. A replay of the presentation will be posted on the
Bruker Corporation Investor Relations website after the event and
will be available for 30 days following the presentation.
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker's high-performance
scientific instruments and high-value analytical solutions enable
scientists to explore life and materials at molecular, cellular and
microscopic levels. In close cooperation with our customers,
Bruker is enabling innovation, productivity and customer success in
life science molecular research, in applied and pharma
applications, in microscopy, nanoanalysis and industrial
applications, as well as in cell biology, preclinical imaging,
clinical research, microbiology and molecular diagnostics.
For more information, please visit: www.bruker.com .
Contact:
Miroslava
Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com
View original
content:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300576613.html
SOURCE Bruker Corporation